WHO Updates Guidelines for COVID-Related Inflammation in Children | | UN News

The updated UN health agency recommendation comes after it first described multisystem inflammatory syndrome in children associated with COVID-19, or MIS-C for short, last Maybe

“MIS-C is a rare but serious condition in which children with COVID-19 develop inflammation that affects various organs in the body.” WHO Press secretary Christian Lindmeier announced this to reporters at a briefing in Geneva.

“Children with this disease need specialized care and may need hospitalization. Although MIS-C is a serious condition, with proper medical care, children with the condition will recover. ”

Most low-risk children

Lindmeier said that while young people remain at low risk of developing severe or critical COVID-19, several underlying factors make them more susceptible to developing severe organ inflammation due to coronavirus

These conditions include obesity, chronic lung disease including asthma, cardiovascular disease, and immune suppression.

The WHO issued its recommendation after analyzing data from three observational studies that combined the experiences of 885 patients.

COVID swept across Europe

Meanwhile, the WHO European Region remains in the grip of the pandemic. Last week, the number of reported COVID-related deaths rose to nearly 4200 daily, which is double the 2,100 deaths per day at the end of September.

And the cumulative reported deaths from the virus have exceeded 1.5 million in 53 countries in the Region.

Today, COVID-19 is the number one cause of death in Europe and Central Asia, according to the Institute for Health Metrics and Evaluation, which is conducting simulations for the WHO Regional Office for Europe.

This was due to the fact that the UN health agency expressed fears that by March next year in Europe, more than two million people could die from the coronavirus.

Vaccine plus approach

“To live with this virus and to continue our daily lives, we need to take a vaccine plus approach,” said Hans Henri P. Kluge, WHO Regional Director for Europe.

To live with this virus and continue our daily lives, we need to take a vaccine plus approach – WHO Director for Europe

This means getting standard doses of vaccine, booster vaccinations if offered, and putting preventive measures into our daily routine.

Taken together, wearing a mask, washing hands, airing rooms, maintaining physical distance, and sneezing into the elbow are simple and effective ways to control the virus and keep the community alive.

“We all have the ability and responsibility to help prevent unnecessary tragedy and loss of life and limit further disruption to society and business this winter,” said Dr. Kluge.

Disturbing symptoms

Before the UN agency decided on a preliminary clinical definition of inflammatory syndrome associated with COVID-19 last year, it was getting reports from Europe and North America describing groups of children and adolescents requiring intensive care “with multisystem inflammatory disease with some features similar to those of Kawasaki disease and toxic shock syndrome.”

At the time, WHO noted that the patients had “an acute illness accompanied by a hyperinflammatory syndrome leading to multiple organ failure and shock … Initial hypotheses are that this syndrome may be related to COVID-19, based on initial laboratory tests showing positive serology. in most patients. ”

Global collection

Latest WHO data indicates that as of Monday, the agency had reported 256,966,237 confirmed cases of COVID-19, including 5,151,643 deaths, and a total of 7,408,870,760 doses of vaccine had been administered.

Regionally, the largest number of infections is in the Americas, with more than 95 million cases, followed by Europe (83 million), Southeast Asia (44 million), Eastern Mediterranean (16 million), Western Pacific ( nine million) and Africa (six million).

© UNICEF Nepal

A health worker tests a young girl for COVID-19 at a fever clinic located next to a hospital in Saptari, Nepal.

Source link

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button